CRO Services
Services
In Vivo Models
Rodent Behavioral Testing
Pathology
Colony Management
Facility Management
By Development Phase
Target Validation
Hit-to-Lead
Lead Optimization
Preclinical Drug Development Services
Clinical Development
By Research Area
Nephrology
Oncology
Immunology
Neurology
Metabolic
Cardiovascular
Research Models
Neurology
In vitro Neurology Assays
Alzheimer’s Disease
Parkinson’s Disease
ALS Disease
Huntington’s Disease
Multiple Sclerosis
Spinal Cord Injury
Spasticity
Duchenne Muscular Dystrophy
Ageing
BBB drug delivery
Immunology
In vitro Immunoassays
Vaccine Testing and mRNA/RNA therapies
Delayed-type hypersensitivity (DTH) Mouse Model
Psoriasis Mouse Model – IL-23 Induced
Type 1 Diabetes Mouse Models
IBD Mouse Models
EAE Mouse Model
Oncology
In Vitro Assays
Syngeneic Models
Cell line-derived Xenografts
Organoid High-Throughput Screening
Patient-derived Xenografts
Humanized Models
Rare Disease
Polycystic Kidney Disease
Fragile X Syndrome
Vanishing White Matter
STXBP1 Epileptic Encephalopathy
Charcot Marie Tooth Disease
Kabuki Syndrome
Angelman Syndrome
Huntington’s Disease
Phelan-McDermid Syndrome
22q11.2 deletion syndrome
Metabolic
DIO Mouse Model
MASH Mouse Model
db/db Mouse Model
Diabetic Cardiomyopathy Rat Model
Type 1 Diabetes Mouse Models
Cardiovascular
Transverse Aortic Constriction (TAC) Mouse Model of Heart Failure
Angiotensin II-induced Hypertension Mouse Model
Diabetic Cardiomyopathy Rat Model
Scientific Repository
Blog
Newsletter Archive
Conferences
About
About InnoSer
Contact
Team
Scientific Board
Research and Development
Privacy Policy
3R's Policy
Vacancies
Select Page
InnoSer – European Preclinical CRO Services – 日本語
